Neurodevelopmental follow-up of very preterm infants after proactive treatment at a gestational age of ≥23 weeks

被引:29
|
作者
Steinmacher, Jochen [2 ,3 ]
Pohlandt, Frank [2 ]
Bode, Harald [3 ]
Sander, Silvia
Kron, Martina
Franz, Axel R. [1 ,2 ]
机构
[1] Univ Bonn, Ctr Pediat, Dept Neonatol, D-53105 Bonn, Germany
[2] Univ Ulm, Dept Pediat, Div Neonatol & Pediat Crit Care, D-7900 Ulm, Germany
[3] Univ Ulm, Dept Pediat, Div Pediat Neurol, D-7900 Ulm, Germany
来源
JOURNAL OF PEDIATRICS | 2008年 / 152卷 / 06期
关键词
D O I
10.1016/j.jpeds.2007.11.004
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective To determine the long-term neurodevelopmental outcome in extremely preterm infants after offering life support to all infants >= 23 weeks gestation ("pro-active management"). Study design With parental consent, all infants born at 23 to 25 completed weeks gestation were treated proactively. Surviving infants born from July 1996 to June 1999 were assessed for standardized cognitive and neurological outcomes at 5 years corrected age. Results 70 of 91 infants admitted to the neonatal intensive care unit survived until follow-up. 67 of die 70 surviving infants were examined at a median corrected age of 5.6 years; 12% had cerebral palsy and a Gross Motor Function Classification Scale score > 2; 4% were blind; 1% required a hearing aid; and 12% had a Kaufmann Assessment Battery for Children mental processing composite < 51, resulting in 18% sustaining a severe disability. 43% had normal results on a neurological examination, Gross Motor Function Classification Scale score = 0, mental processing composite > 85, and had neither severe visual nor hearing impairment. 57% qualified for regular schooling. Conclusion improved survival was not associated with an increased risk of severe disability when compared with results of earlier publications. These findings may result from proactive management and are important for counseling patients at risk of imminent extremely preterm delivery.
引用
收藏
页码:771 / 776
页数:6
相关论文
共 50 条
  • [31] The effect of gestational age on major neurodevelopmental disorders in preterm infants
    Mads L. Larsen
    Rikke Wiingreen
    Andreas Jensen
    Gija Rackauskaite
    Bjarne Laursen
    Bo M. Hansen
    Christina E. Hoei-Hansen
    Gorm Greisen
    [J]. Pediatric Research, 2022, 91 : 1906 - 1912
  • [32] Neurological Examination and Hearing Assessment of Premature Infants with Gestational Age of Less Than 32 Weeks at Follow-up
    Vohra, Arif
    Vaishnav, Jolly
    Pathan, Nargis
    [J]. IRANIAN JOURNAL OF NEONATOLOGY, 2023, 14 (02) : 40 - 45
  • [33] Ophthalmological follow-up of preterm infants
    Holmstrom, G
    ElAzazi, M
    Kugelberg, U
    [J]. SOE '97 - XI CONGRESS OF THE EUROPEAN SOCIETY OF OPHTHALMOLOGY, VOLS 1 AND 2, 1997, : 953 - 956
  • [34] OPHTHALMOLOGICAL FOLLOW-UP IN PRETERM INFANTS
    KULNIG, W
    SALZER, H
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 1986, 98 (09) : 288 - 291
  • [35] FOLLOW-UP OF PRETERM INFANTS AFTER PRENATAL BETAMETHASONE (BETA)
    BALLARD, RA
    CLARK, C
    CLYMAN, RI
    DEKLE, M
    LEONARD, CH
    ROTH, RS
    SEHRING, S
    SNIDERMAN, S
    [J]. PEDIATRIC RESEARCH, 1981, 15 (04) : 648 - 648
  • [36] Gentamicin pharmacokinetics in preterm infants ≤ 28 weeks gestational age
    Aouthmany, MM
    Batista, DL
    Fenn-Boderer, NM
    Gillikin, S
    [J]. PEDIATRIC RESEARCH, 1999, 45 (04) : 64A - 64A
  • [37] Vancomycin pharmacokinetics in preterm infants ≤ 28 weeks gestational age
    Aouthmany, MM
    Batista, DL
    Fenn-Boderer, NM
    Gillikin, S
    [J]. PEDIATRIC RESEARCH, 1999, 45 (04) : 266A - 266A
  • [38] Vancomycin Pharmacokinetics in Preterm Infants ≤ 28 Weeks Gestational Age
    M M Aouthmany
    D L Batista
    N M Fenn-Boderer
    S Gillikin
    [J]. Pediatric Research, 1999, 45 : 266 - 266
  • [39] Gentamicin pharmacokinetics in preterm infants ≤28 weeks gestational age
    Aouthmany, MM
    Batista, DL
    Fenn-Buderer, NM
    Gillikin, S
    [J]. PEDIATRICS, 1999, 104 (03) : 745 - 746
  • [40] Gentamicin Pharmacokinetics in Preterm Infants ≤ 28 Weeks Gestational Age
    M M Aouthmany
    D L Batista
    N M Fenn-Boderer
    S Gillikin
    [J]. Pediatric Research, 1999, 45 : 64 - 64